Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer

NCT02420977 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Advanced Prostate Cancer

Interventions

DRUG: Pelvic DCFPyL PET-MRI fusion or PET/MRI

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]